Blood flow and pO2 changes after vascular-targeted
photodynamic therapy (V-
PDT) or cellular-targeted
PDT (C-
PDT) using 5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)
bacteriochlorin (F2BMet) as
photosensitizer were investigated in DBA/2 mice with S91 Cloudman mouse
melanoma, and correlated with long-term
tumor responses. F2BMet generates both
singlet oxygen and
hydroxyl radicals under near-infrared radiation, which consume
oxygen. Partial
oxygen pressure was lowered in
PDT-treated
tumors and this was ascribed both to oxygen consumption during
PDT and to fluctuations in
oxygen transport after
PDT. Similarly, microcirculatory blood flow changed as a result of the disruption of blood vessels by the treatment. A novel noninvasive approach combining electron paramagnetic resonance oximetry and
laser Doppler blood perfusion measurements allowed longitudinal monitoring of
hypoxia and vascular function changes in the same animals, after
PDT. C-
PDT induced parallel changes in
tumor pO2 and blood flow, i.e., an initial decrease immediately
after treatment, followed by a slow increase. In contrast, V-
PDT led to a strong and persistent depletion of pO2, although the microcirculatory blood flow increased. Strong
hypoxia after V-
PDT led to a slight increase in
VEGF level 24h
after treatment. C-
PDT caused a ca. 5-day delay in
tumor growth, whereas V-
PDT was much more efficient and led to
tumor growth inhibition in 90% of animals. The
tumors of 44% of mice treated with V-
PDT regressed completely and did not reappear for over 1 year. In conclusion, mild and transient
hypoxia after C-
PDT led to intense pO2 compensatory effects and modest
tumor inhibition, but strong and persistent local
hypoxia after V-
PDT caused
tumor growth inhibition.